Ns Pharma, Inc.
Clinical trials sponsored by Ns Pharma, Inc., explained in plain language.
-
New pill could ease strain on Lungs' blood vessels
Disease control Not yet recruitingThis study tests an oral medication called NS-863 in people with pulmonary arterial hypertension (PAH), a condition where blood vessels in the lungs narrow, making the heart work harder. About 135 adults will receive either NS-863 or a placebo for 24 weeks to see if the drug impr…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 11:34 UTC
-
New pill aims to ease Lung-Heart strain in rare disease
Disease control Not yet recruitingThis study tests an oral drug called NS-863 in 177 adults with pulmonary hypertension linked to interstitial lung disease. The goal is to see if it improves blood flow in the lungs and is safe. Participants will be randomly assigned to receive the drug or a placebo for about 24 w…
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC